Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29038340

Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged ≥60 years with HL.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2017 Dec 28
First author
Friedberg JW

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2017 Dec 28;130(26):2813-2814. doi: 10.1182/blood-2017-10-812966.
    note
    Source null
    related pmid
    29284610
    relationship
    Comment in

Authors and identifiers

  1. name
    Friedberg JW
    type
    Author
  2. name
    Forero-Torres A
    type
    Author
  3. name
    Bordoni RE
    type
    Author
  4. name
    Cline VJM
    type
    Author
  5. name
    Patel Donnelly D
    type
    Author
  6. name
    Flynn PJ
    type
    Author
  7. name
    Olsen G
    type
    Author
  8. name
    Chen R
    type
    Author
  9. name
    Fong A
    type
    Author
  10. name
    Wang Y
    type
    Author
  11. name
    Yasenchak CA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Friedberg JW
    type
    Author
  2. name
    Forero-Torres A
    type
    Author
  3. name
    Bordoni RE
    type
    Author
  4. name
    Cline VJM
    type
    Author
  5. name
    Patel Donnelly D
    type
    Author
  6. name
    Flynn PJ
    type
    Author
  7. name
    Olsen G
    type
    Author
  8. name
    Chen R
    type
    Author
  9. name
    Fong A
    type
    Author
  10. name
    Wang Y
    type
    Author
  11. name
    Yasenchak CA
    type
    Author
bibliography ids
  1. nci-bib-49f868f3756e6235fae8657b
book metadata
content sha256
42b44fc77d6374c28d12508deef7790cd0f67f5912a71f481507fdfd543a9f5c
document type
citation
dois
  1. 10.1182/blood-2017-06-787200
electronic publication date
display
2017 Oct 16
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:29038340
immutable id
pubmed:29038340@42b44fc77d6374c28d12508deef7790cd0f67f5912a71f481507fdfd543a9f5c
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
26
name
Blood
nlm unique id
7603509
pages
2829-2837
volume
130
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2017 Dec 28;130(26):2813-2814. doi: 10.1182/blood-2017-10-812966.
    note
    Source null
    related pmid
    29284610
    relationship
    Comment in
outcomes validated
false
pmid
29038340
provenance
batch id
fb25b16edcb1373b70c1
provider
NCBI PubMed ESummary
record sha256
49da064934dd6dfde6afe260426ee0ad07a1b9d5d30615f4907fc0910e4b94cb
response sha256
182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
retrieved at
2026-09-09T23:47:28.490065+00:00
publication date
display
2017 Dec 28
precision
day
year
2017
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29038340/
title
Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged ≥60 years with HL.

Preserved source evidence · Not medical advice